Abstract:Background: Inclusion bodies (IBs) are protein aggregates in recombinant bacterial cells containing mainly the target recombinant protein. Although it has been shown that IBs contain functional proteins along with protein aggregates, their direct application as pharmaceuticals is hindered by their heterogeneity and hazardous contaminants with bacterial origin. Therefore, together with the production of soluble species, IBs remain the main source for manufacture of recombinant proteins with medical application. The quality and composition of the IBs affect the refolding yield and further purification of the recombinant protein. The knowledge whether nucleic acids are genuine components or concomitant impurities of the IBs is a prerequisite for the understanding of the IBs formation and for development of optimized protocols for recombinant protein refolding and purification. IBs isolated from Escherichia coli overexpressing human interferon-gamma (hIFNγ), a protein with therapeutic application, were used as a model. Results: IBs were isolated from E. coli LE392 cells transformed with a hIFNγ expressing plasmid under standard conditions and further purified by centrifugation on a sucrose cushion, followed by several steps of sonication and washings with non-denaturing concentrations of urea. The efficiency of the purification was estimated by SDS-PAGE gel electrophoresis and parallel microbiological testing for the presence of residual intact bacteria. Phenol/chloroform extraction showed that the highly purified IBs contain both DNA and RNA. The latter were studied by UV spectroscopy and agarose gel electrophoresis combined with enzymatic treatment and hybridization. DNA was observed as a diffuse fraction mainly in the range of 250 to 1000 bp. RNA isolated by TRIzol® also demonstrated a substantial molecular heterogeneity. Hybridization with 32P-labelled oligonucleotides showed that the IBs contain rRNA and are enriched of hIFNγ mRNA. Conclusions: The results presented in this study indicate that the nucleic acids might be intrinsic components rather than co-precipitated impurities in the IBs. We assume that the nucleic acids are active participants in the aggregation of recombinant proteins and formation of the IBs that originate from the transcription and translation machinery of the microbial cell factory. Further studies are needed to ascertain this notion.

Refolding of recombinant human interferon-gamma by expanded bed adsorption chromatography with urea gradient

Integration of Expanded Bed Adsorption and Hydrophobic Charge-Induction Chromatography for Monoclonal Antibody Separation

Separation and Purification of Immunoglobulin IgY with Hydrophobic Charge-Induction Expanded Bed Adsorption

5-Aminobenzimidazole as new hydrophobic charge-induction ligand for expanded bed adsorption of bovine IgG

The Influence of Homogenisation Conditions on Biomass‐adsorbent Interactions During Ion‐exchange Expanded Bed Adsorption

Process Design in Expanded Bed Adsorption - Integrating Target Adsorption and Biomass Influence

An Integrated Expanded Bed Adsorption Process for Lactoferrin and Immunoglobulin G Purification from Crude Sweet Whey.

Refolding of Recombinant Human Interferon Gamma Inclusion Bodies in Vitro Assisted by Colloidal Thermo-Sensitive Poly(n-Isopropylacrylamide) Brushes Grafted Onto the Surface of Uniform Polystyrene Cores

A Simplified Process for Purification and Refolding of Recombinant Human Interferon-α2b

Expression, Purification, and Refolding of a Recombinant Human Bone Morphogenetic Protein 2 in Vitro

Refolding and two-step purification by hydrophobic interaction chromatography of recombinant human bone morphogenetic protein-2 from Escherichia coli

High hydrostatic pressure refolding of highly hydrophobic protein: A case study of recombinant human interferon β-1b from inclusion bodies

Purification and Refolding Escherichia Coli Produced Enterokinase Inclusion Bodies Immobilized by Nickel Chelating Chromatography

Solvent extraction of recombinant interferon alpha-2b from inclusion bodies and efficient refolding at high protein concentrations

Highly Efficient Production of Soluble Proteins from Insoluble Inclusion Bodies by a Two-Step-denaturing and Refolding Method.

Nucleic acids in inclusion bodies obtained from E. coli cells expressing human interferon-gamma

Purification, Refolding of Hybrid Hifnγ-Kringle 5 Expressed in Escherichia Coli

Recombinant human epidermal growth factor inclusion body solubilization and refolding at large scale using expanded-bed adsorption chromatography from Escherichia coli

Purification and characterization of recombinant human interferon-γ from Chinese Han nationality

Purification of inclusion bodies using PEG precipitation under denaturing conditions to produce recombinant therapeutic proteins from Escherichia coli

Refolding of ribonuclease A in vitro and conformational characterization by spectrofluorimetry